Device Cardiology/Vascular Diseases

Cardiohelp

Payments companies reported to CMS as associated with Cardiohelp. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$59Kassociated payments (2023-2025)
589clinicians with associated payments
2companies reporting

By year

2023 $39K
2024 $11K
2025 $9,252

Payments reported as associated with Cardiohelp, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $9,688
Critical Care Medicine (Internal Medicine) $8,260
Thoracic Surgery (Cardiothoracic Vascular Surgery) $7,280
Cardiovascular Disease $3,769
Surgical $3,590
Emergency Medicine $3,204

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cardiohelp

These are the largest totals companies reported as associated with Cardiohelp. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mohammad Ansari Lubbock, TX Interventional Cardiology $3,600.00
Eddy Fan Baltimore, MD Critical Care Medicine (Internal Medicine) $2,490.00
Jay Mohan Mount Clemens, MI Interventional Cardiology $1,600.00
Arvind Bhimaraj Houston, TX Advanced Heart Failure and Transplant Cardiology $1,600.00
James Keuler Milwaukee, WI Surgical $1,500.00
Demetris Yannopoulos Minneapolis, MN Interventional Cardiology $1,430.00
Maria Creel Bulos St Louis, MO Emergency Medicine $683.55
Tyler Vandyck Pittsburgh, PA Critical Care Medicine (Internal Medicine) $498.81
Mazen Odish San Diego, CA Critical Care Medicine (Internal Medicine) $492.07
Subbarao Elapavaluru Pittsburgh, PA Critical Care Medicine (Internal Medicine) $430.10

Prescribed Cardiohelp?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.